Dave Bhargav
Clinical Research Analyst and Professor, Srinivas University , Mangaluru, Karnataka, India .
J Clin Diagn Res. 2016 Sep;10(9):OE01-OE07. doi: 10.7860/JCDR/2016/21853.8396. Epub 2016 Sep 1.
Chronic Total Occlusion (CTO) has been considered as one of the "final frontier" in interventional cardiology. Until recently, the patients with CTO are often managed surgically or medically due to lack of published evidence of clinical benefits and lower success rate of percutaneous recanalization of CTO. However, the introduction of enhanced guidewires, microcatheters combined with novel specialized devices and techniques reduce the number of unapproachable CTO. In this review article, current techniques and devices of percutaneous recanalization of CTO have been systematically summarized, which may help budding interventional cardiologists to theoretically understand these complex procedures and to deliver safe and effective percutaneous management of CTO to the patients.
慢性完全闭塞病变(CTO)一直被视为介入心脏病学中的“最后前沿阵地”之一。直到最近,由于缺乏已发表的关于临床益处的证据以及CTO经皮再通成功率较低,CTO患者通常采用外科手术或药物治疗。然而,增强型导丝、微导管与新型专业设备和技术的引入减少了难以处理的CTO数量。在这篇综述文章中,系统总结了目前CTO经皮再通的技术和设备,这可能有助于初出茅庐的介入心脏病学家从理论上理解这些复杂的操作,并为患者提供安全有效的CTO经皮治疗。